Effect of Agave Syrup, Placebo, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Infants/Toddlers and Their Parents

Cough is a frequent symptom in children and infants and is one of the most common reasons parents visit a healthcare provider for their child. The US Food and Drug Administration has issued a warning that over-the-counter cough and cold medicines including antihistamines, decongestants, anti-tussives, and expectorants should not be administered to children younger than 2 years of age due not only to lack of proven efficacy, but also because of important safety concerns. Honey, another method of soothing cough cannot be used in children <1 year due to concerns for infantile botulism. A preparation from agave syrup has been created to address the need for an infant cough syrup. Although no studies have formally evaluated the use of agave nectar for nocturnal cough associated with Upper Respiratory Infections, the demulcent effect and sweet taste of agave nectar may provide some relief from cough in children.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cough Dyssomnias Mental Disorders Nervous System Diseases Pathological Conditions, Signs and Symptoms Respiration Disorders Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory Sleep Disorders, Intrinsic Sleep Initiation and Maintenance Disorders Sleep Wake Disorders

Age range

2 month–48 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Penn State Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Otherwise healthy male or female infant who is 2 to <48 months of age.
presents with a non-specific acute cough for 7 or fewer days' duration.
Parents/legal authorized representative reporting at least moderate cough and cold symptoms.
Parent/legal authorized representative was in the home with the child on the night prior to enrollment and plans to be in the home with the child on the night when study treatment will be administered
Parent/legal authorized representative who is willing and able to comply with study requirements.

Exclusion criteria

Previous participation in this clinical trial
Gestational age at birth <35 weeks.
Signs or symptoms of a more treatable disease (eg, asthma, pneumonia, laryngotracheobronchitis, sinusitis, allergic rhinitis).
Diagnosis of influenza, bronchiolitis or respiratory syncytial virus (RSV).
History of reactive airways disease, asthma, or chronic lung disease.
Use of any medication or honey to treat cough within 6 hours of bedtime on the evening prior to or on the day of enrollment.
Presence of any significant disease including immunodeficiency, hepatic, renal,cardiovascular, or hematologic disease or any other health condition that, in the opinion of the investigator, would preclude participation in the study.
Known allergy to agave nectar or grape flavoring

Treatment and study plan

Agave Syrup

Dietary Supplement

Other names: Zarbee's Naturals Agave Baby Cough Syrup

Primary outcomes

Efficacy:Change in Cough Frequency based on parent responses to the Pediatric Cough Questionnaire

Time frame: Baseline (night 1) and End of night 2

Change from baseline in cough frequency between the first night and the end of the second night. Parents/caregivers will complete a Pediatric Cough Questionnaire (a subjective parent report of cough) using a 0-6 point Likert scale with 0=not at all to 6=extremely often to assess frequency of cough. The same parent/caregiver that completed the questionnaire in the clinic will be asked to complete the questionnaire during the follow-up telephone call.

Secondary outcomes

Efficacy: Change in Response to Other symptom responses on the Pediatric Cough Questionnaire(parental report)

Time frame: Change from Baseline (night 1) to End of Second Night
Change from baseline (night 1) and the end of the second night for each of the remaining questionnaire items pertaining to cough and cold symptoms and the symptoms affect on sleep.

Parents/caregivers will complete a Pediatric Cough Questionnaire (a subjective parent report of cold symptoms) using a 0-6 point Likert scale with 0=not at all to 6=extremely often to assess cold symptoms.
- severity of cough
- bothersome nature of cough
- how much the cough affected the child's and parent's/caregiver's ability to sleep
- severity of stuffy nose
- severity of runny nose The same parent/caregiver that completed the questionnaire in the clinic will be asked to complete the questionnaire during the follow-up telephone call.

Sponsors and collaborators

Lead sponsor

Penn State University

Other

Collaborators

Zarbee's Inc.

Registry information

Important dates

Study start: 2013
Primary completion: 2014
Study completion: 2014
First posted: Nov 5, 2012
Registry last updated: Oct 23, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed